ArticleCanadian journal of kidney health and disease2020

Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin.

Rachel Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.